 Justin Honce
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 18 | 2026 | 3917 | 1.140 |
Why?
| | Comprehension | 1 | 2025 | 175 | 0.790 |
Why?
| | Multiple Sclerosis | 4 | 2021 | 434 | 0.730 |
Why?
| | Immunologic Factors | 2 | 2019 | 244 | 0.600 |
Why?
| | Glatiramer Acetate | 1 | 2019 | 11 | 0.580 |
Why?
| | Psychotherapy | 1 | 2020 | 179 | 0.550 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 66 | 0.540 |
Why?
| | Rituximab | 1 | 2019 | 208 | 0.530 |
Why?
| | Epilepsy | 2 | 2017 | 397 | 0.420 |
Why?
| | Neuroimaging | 1 | 2016 | 306 | 0.390 |
Why?
| | Meningeal Neoplasms | 3 | 2021 | 95 | 0.330 |
Why?
| | Cochlear Implantation | 2 | 2023 | 74 | 0.310 |
Why?
| | Cochlear Implants | 2 | 2023 | 86 | 0.310 |
Why?
| | Artifacts | 3 | 2026 | 142 | 0.300 |
Why?
| | Natalizumab | 2 | 2021 | 30 | 0.300 |
Why?
| | Meningioma | 2 | 2021 | 87 | 0.300 |
Why?
| | Brain Concussion | 1 | 2016 | 660 | 0.260 |
Why?
| | Central Nervous System | 2 | 2021 | 278 | 0.260 |
Why?
| | Brain | 5 | 2024 | 2981 | 0.250 |
Why?
| | Pyrimidines | 2 | 2021 | 530 | 0.240 |
Why?
| | Pyrazoles | 3 | 2021 | 516 | 0.240 |
Why?
| | Bone Conduction | 1 | 2026 | 21 | 0.240 |
Why?
| | High-Intensity Focused Ultrasound Ablation | 1 | 2026 | 13 | 0.230 |
Why?
| | Hearing Aids | 1 | 2026 | 45 | 0.230 |
Why?
| | Essential Tremor | 1 | 2026 | 24 | 0.230 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 1194 | 0.220 |
Why?
| | Atrophy | 2 | 2024 | 199 | 0.210 |
Why?
| | Skull | 1 | 2026 | 162 | 0.210 |
Why?
| | Middle Aged | 16 | 2025 | 36359 | 0.210 |
Why?
| | Pyridines | 2 | 2021 | 606 | 0.200 |
Why?
| | Frontotemporal Dementia | 1 | 2024 | 56 | 0.200 |
Why?
| | Parkinson Disease | 3 | 2026 | 614 | 0.180 |
Why?
| | Humans | 29 | 2026 | 145625 | 0.180 |
Why?
| | Central Nervous System Diseases | 1 | 2023 | 73 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 105 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2021 | 41 | 0.170 |
Why?
| | Patient Satisfaction | 1 | 2025 | 698 | 0.160 |
Why?
| | Lung Neoplasms | 3 | 2021 | 2674 | 0.160 |
Why?
| | Adult | 12 | 2025 | 40821 | 0.160 |
Why?
| | Relaxation Therapy | 1 | 2020 | 19 | 0.160 |
Why?
| | Hypnosis | 1 | 2020 | 12 | 0.160 |
Why?
| | Radiology Department, Hospital | 1 | 2019 | 16 | 0.150 |
Why?
| | Radiology, Interventional | 1 | 2020 | 49 | 0.150 |
Why?
| | Software | 1 | 2024 | 673 | 0.150 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 30 | 0.140 |
Why?
| | Maintenance Chemotherapy | 1 | 2019 | 41 | 0.140 |
Why?
| | Cerebral Arterial Diseases | 1 | 2019 | 50 | 0.140 |
Why?
| | Neurologic Examination | 1 | 2019 | 129 | 0.140 |
Why?
| | Lactams, Macrocyclic | 1 | 2018 | 51 | 0.140 |
Why?
| | Antineoplastic Agents | 2 | 2021 | 2218 | 0.140 |
Why?
| | Blepharospasm | 1 | 2018 | 7 | 0.140 |
Why?
| | Induction Chemotherapy | 1 | 2019 | 87 | 0.140 |
Why?
| | Demyelinating Diseases | 1 | 2019 | 78 | 0.140 |
Why?
| | Torticollis | 1 | 2018 | 21 | 0.140 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 10 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2024 | 640 | 0.130 |
Why?
| | Basal Ganglia | 1 | 2018 | 60 | 0.130 |
Why?
| | Fingolimod Hydrochloride | 1 | 2018 | 35 | 0.130 |
Why?
| | Organophosphorus Compounds | 1 | 2018 | 84 | 0.130 |
Why?
| | Disability Evaluation | 1 | 2019 | 297 | 0.130 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2017 | 24 | 0.130 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 39 | 0.120 |
Why?
| | Spin Labels | 1 | 2016 | 60 | 0.120 |
Why?
| | Male | 15 | 2025 | 73014 | 0.120 |
Why?
| | Brain Neoplasms | 2 | 2016 | 1324 | 0.120 |
Why?
| | Cerebellum | 1 | 2018 | 225 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2019 | 560 | 0.120 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 86 | 0.120 |
Why?
| | Female | 15 | 2025 | 79080 | 0.120 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 104 | 0.110 |
Why?
| | Medical Marijuana | 1 | 2017 | 119 | 0.110 |
Why?
| | Laser Therapy | 1 | 2017 | 146 | 0.110 |
Why?
| | Brain Ischemia | 1 | 2019 | 362 | 0.110 |
Why?
| | Gene Rearrangement | 1 | 2015 | 155 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 6050 | 0.100 |
Why?
| | Gray Matter | 1 | 2015 | 96 | 0.100 |
Why?
| | Immunosuppressive Agents | 1 | 2019 | 824 | 0.100 |
Why?
| | Mitochondrial Diseases | 1 | 2015 | 94 | 0.100 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 207 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2019 | 2064 | 0.100 |
Why?
| | Cerebrovascular Circulation | 1 | 2016 | 293 | 0.100 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 135 | 0.100 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 226 | 0.100 |
Why?
| | Anxiety | 1 | 2020 | 1118 | 0.090 |
Why?
| | Endovascular Procedures | 1 | 2017 | 385 | 0.090 |
Why?
| | Glioma | 1 | 2016 | 425 | 0.090 |
Why?
| | Contrast Media | 3 | 2021 | 492 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1101 | 0.080 |
Why?
| | Brain Injuries | 1 | 2016 | 499 | 0.080 |
Why?
| | Quality Improvement | 1 | 2019 | 1325 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1500 | 0.080 |
Why?
| | Retrospective Studies | 7 | 2026 | 17291 | 0.080 |
Why?
| | Cannabis | 1 | 2017 | 519 | 0.080 |
Why?
| | Stroke | 1 | 2019 | 1283 | 0.070 |
Why?
| | Young Adult | 3 | 2021 | 14240 | 0.070 |
Why?
| | Hippocampus | 1 | 2015 | 986 | 0.070 |
Why?
| | Aged | 8 | 2024 | 26251 | 0.070 |
Why?
| | Quality of Life | 1 | 2021 | 3187 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1992 | 0.060 |
Why?
| | Temporal Bone | 1 | 2026 | 43 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2015 | 1098 | 0.060 |
Why?
| | Treatment Outcome | 4 | 2026 | 11744 | 0.050 |
Why?
| | Cadaver | 1 | 2026 | 302 | 0.050 |
Why?
| | Adolescent | 2 | 2021 | 22451 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3396 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2024 | 8351 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2023 | 23 | 0.050 |
Why?
| | Angiography, Digital Subtraction | 1 | 2022 | 51 | 0.050 |
Why?
| | Cerebral Angiography | 1 | 2022 | 121 | 0.040 |
Why?
| | Computed Tomography Angiography | 1 | 2022 | 151 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 627 | 0.040 |
Why?
| | Dementia | 1 | 2024 | 322 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2857 | 0.040 |
Why?
| | Hospital Bed Capacity, 500 and over | 1 | 2019 | 4 | 0.040 |
Why?
| | Time Management | 1 | 2019 | 20 | 0.040 |
Why?
| | Magnets | 1 | 2019 | 21 | 0.040 |
Why?
| | Transportation of Patients | 1 | 2019 | 62 | 0.040 |
Why?
| | Appointments and Schedules | 1 | 2019 | 97 | 0.040 |
Why?
| | Lactams | 1 | 2018 | 28 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 142 | 0.030 |
Why?
| | Prognosis | 2 | 2019 | 4331 | 0.030 |
Why?
| | Drug Approval | 1 | 2018 | 93 | 0.030 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2018 | 21 | 0.030 |
Why?
| | Databases, Bibliographic | 1 | 2018 | 30 | 0.030 |
Why?
| | Aminopyridines | 1 | 2018 | 128 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2018 | 83 | 0.030 |
Why?
| | Gadolinium | 1 | 2018 | 78 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2022 | 385 | 0.030 |
Why?
| | Dura Mater | 1 | 2017 | 40 | 0.030 |
Why?
| | Mood Disorders | 1 | 2017 | 129 | 0.030 |
Why?
| | Lymphoma, B-Cell | 1 | 2018 | 149 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 782 | 0.030 |
Why?
| | Memory Disorders | 1 | 2017 | 197 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 693 | 0.030 |
Why?
| | Radiosurgery | 1 | 2019 | 398 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1125 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 538 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 364 | 0.030 |
Why?
| | Memory | 1 | 2017 | 298 | 0.030 |
Why?
| | Fatigue | 1 | 2017 | 362 | 0.030 |
Why?
| | Limbic System | 1 | 2015 | 55 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1372 | 0.030 |
Why?
| | Gait Disorders, Neurologic | 1 | 2015 | 43 | 0.030 |
Why?
| | Affect | 1 | 2017 | 317 | 0.030 |
Why?
| | Tremor | 1 | 2015 | 98 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1269 | 0.030 |
Why?
| | Marijuana Smoking | 1 | 2017 | 248 | 0.030 |
Why?
| | Length of Stay | 1 | 2019 | 1342 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2097 | 0.020 |
Why?
| | Internet | 1 | 2017 | 656 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2766 | 0.020 |
Why?
| | Anticoagulants | 1 | 2017 | 743 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2910 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4588 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2101 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5397 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 7079 | 0.020 |
Why?
| | Obesity | 1 | 2017 | 3123 | 0.010 |
Why?
|
|
Honce's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|